Whereas the tumor sizes from the mice immunized with PBS (Fig. 1a) were bigger than that of mice immunized with the CD117+CD44+CSC (***p < 0.003); the time of tumor occurrence was also earlyer than that of mice immunized with the other vaccines (*p < 0.05). This evidence concerns the gene KIT and neoplasm.